Bank Of New York Mellon Corp Green Light Biosciences Holdings, Pbc Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.34 - $1.19 $83,913 - $293,697	246,805 New	246,805 $107 Million
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.0 $246,792 - $479,208	239,604 New	239,604 $282,000
Q3 2022 Nov 14, 2022	BUY	$0.42 - $3.92 $69,255 - $646,380	164,893 Added 340.43%	213,329 $495,000
Q2 2022 Aug 15, 2022	BUY	N/A	23,028 Added 90.63%	48,436 $107,000
Q1 2022 May 11, 2022	BUY	N/A	25,408 New	25,408 $245,000

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.